Baxter (NYSE:BAX) and its subsidiary Gambro filed a patent infringement lawsuit against B. Braun last week, claiming that the German medical device maker’s Omni blood purification system infringes on seven of the patents covering Baxter’s Prismaflex system. The devices are used to treat patients who have acute kidney injuries and need help filtering out the waste […]
Gambro
China halts anti-dumping probe into EU, Japan dialysis kit makers
NxStage, Gambro bury the hatchet, renew supply deal
Baxter and Gambro seal the deal on $3.9B acquisition
Aussie regulators approve Baxter’s $4B Gambro merger
Baxter appeases EU regulators in $4B Gambro buyout
Sources say Baxter’s near an agreement with EU regulators in $4B Gambro merger
Baxter aims to soothe E.U. antitrust concerns over $4B Gambro merger
Greatbatch raises 2013 guidance on restructuring efforts | Wall Street Beat
Texas medical device maker Greatbatch (NYSE:GB) raised its 2013 per-share earnings guidance as it announced new efforts to reorganize some of its business practices and reduce costs as it shifts from a components and sub-assemblies company to a developer of full medical devices.
Medtronic closes strategic investment in LifeTech | Wall Street Beat
Medtronic (NYSE:MDT) said it’s closed a $66 million investment in Chinese medical device company LifeTech Scientific (HK:8122).
